Industry Overview
The Global Tumor Ablation Market valued at USD 1.48 billion in 2023 is expected to grow during the forecasted period of 2025 to 2030. With a prospective CAGR of 12.2%, the market is expected to reach a value of USD 4.22 billion by 2030.
The tumor ablation market is a rapidly growing sector in the healthcare industry. It is a minimally invasive procedure that destroys cancerous tissue by applying heat or cold to the tumor. The procedure is an alternative to traditional surgery, chemotherapy, and radiation therapy, and is gaining popularity due to its low risk of complications and shorter recovery time. The market for tumor ablation is expected to grow significantly in the coming years due to the increasing incidence of cancer and the rising demand for minimally invasive procedures.
Tumor Ablation Market Segmentation
The tumor ablation market can be segmented in various ways based on different factors such as technology, mode of treatment, application, and end-user.
Insight By Technology:
- Radiofrequency ablation (RFA)
- Microwave ablation
- Cryoablation
- Irreversible Electroporation (IRE)
- Others
RFA technology has been the most widely used and established technique for tumor ablation. RFA technology is expected to continue to dominate the tumor ablation market due to its lower cost, widespread adoption, and extensive clinical data. Additionally, technological advancements, such as the development of ultrasound-guided RFA systems and the integration of
RFA technology with MRI is expected to further drive the growth of the RFA market.
Along with this, the microwave ablation market is also expected to grow rapidly due to its ability to achieve higher temperatures and faster ablation times than RFA. Microwave ablation is particularly effective for large tumors and is also a promising option for lung cancer ablation.
Cryoablation:
Cryoablation technology is expected to grow due to its advantages over other ablation technologies, including low complication rates, minimal damage to surrounding tissues, and the ability to treat larger tumors.
Insight By Mode of Treatment
- Surgical Ablation
- Percutaneous Ablation
- Laparoscopic Ablation
Percutaneous ablation is a minimally invasive procedure that involves the insertion of a needle or probes directly into the tumor, guided by imaging techniques. The percutaneous ablation market is expected to grow rapidly due to its advantages over surgical ablation, such as shorter hospital stays, fewer complications, and lower costs. Radiofrequency ablation (RFA), microwave ablation, and cryoablation are commonly used percutaneous ablation techniques.
Laparoscopic ablation involves the insertion of a laparoscope, a thin, lighted tube with a camera, through a small incision in the abdomen. The laparoscopic ablation market is expected to drive global market growth due to its ability to treat tumors in hard-to-reach areas, such as the liver and pancreas, and its advantages over surgical ablation, such as shorter hospital stays and less scarring.
Insight By Application:
- Liver Cancer
- Lung Cancer
- Prostate Cancer
- Breast Cancer
- Kidney Cancer
- Bone Cancer
- Others
The liver cancer ablation market is expected to see the most significant growth due to the high incidence of liver cancer globally. However, other application areas, such as lung cancer, prostate cancer, and breast cancer, are expected to grow rapidly due to the development of new ablation techniques and rising cancer incidence rates.
Additionally, the lung cancer ablation market is expected to fuel the expansion of the global market size through its increasing prevalence and the development of minimally invasive ablation techniques, such as microwave ablation and cryoablation.
Insight by End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
The end-user market plays a crucial role in the growth of the global tumor ablation market. The success of any medical technology depends on its adoption and acceptance by end-users. Hospitals are the largest end-user of tumor ablation technologies. The demand for tumor ablation technologies in hospitals is increasing due to the rising incidence of cancer and the increasing number of minimally invasive procedures.
Ambulatory surgical centers (ASCs) are also significant end-user of tumor ablation technologies. ASCs offer a cost-effective and efficient alternative to hospitals for minimally invasive procedures. The demand for tumor ablation technologies in ASCs is expected to increase due to their ability to offer same-day procedures and reduce healthcare costs.
Global Tumor Ablation Market Report Coverage
|
Report Metric
|
Details
|
|
Historical Period
|
2018 - 2023
|
|
Base Year Considered
|
2024
|
|
Forecast Period
|
2025 - 2030
|
|
Market Size in 2024
|
U.S.D. 1.48 Billion
|
|
Revenue Forecast in 2030
|
U.S.D. 4.22 Billion
|
|
Growth Rate
|
12.2%
|
|
Segments Covered in the Report
|
By Technology, By Mode of Treatment, By Application and By End User
|
|
Report Scope
|
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
|
|
Regions Covered in the Report
|
North America, Europe, Asia-Pacific, Middle East, and Rest of the World
|
Tumor Ablation Market Growth Drivers
The increasing incidence of cancer is a major driver of the tumor ablation market. According to the World Health Organization (WHO), cancer is the second leading cause of death globally, with an estimated 9.6 million deaths in 2018. The rising incidence of cancer is leading to an increase in the demand for minimally invasive procedures like tumor ablation.
Another driver of the tumor ablation market is the rising demand for minimally invasive procedures. Tumor ablation is a minimally invasive procedure that offers several advantages over traditional surgery, chemotherapy, and radiation therapy. The procedure is associated with a lower risk of complications, shorter recovery time, and improved quality of life for patients. Technological advancements in tumor ablation procedures are also driving the market. The development of new technologies like radiofrequency ablation, microwave ablation, and cryoablation has improved the efficacy of the procedure and expanded its applications.
Tumor Ablation Market Challenges
Tumor ablation refers to the destruction of cancerous tumors through various methods, including radiofrequency ablation, microwave ablation, cryoablation, and others. While the tumor ablation market has grown significantly in recent years, there are still several challenges that could hinder its continued growth. Here are some of the challenges facing the tumor ablation market are as below:
High cost: Tumor ablation procedures can be expensive, which may limit their use in certain markets. In addition, the cost of the equipment required for these procedures can be prohibitively high for some healthcare providers.
Limited awareness: Despite the growth of the tumor ablation market, there is still limited awareness among healthcare providers and patients about these procedures. This lack of awareness may limit the adoption of tumor ablation as a treatment option.
Recent Developments By the Key Players
AngioDynamics has teamed up with the University College London Hospital (UCLH) in the UK to launch a prospective registry study evaluating the long-term effects of the NanoKnife system for treating unifocal intermediate-risk prostate cancer.
EDAP TMS SA, the global leader in robotic energy-based therapies, and Avenda Health, a leading AI healthcare company, has collaborated to offer personalized prostate cancer care, utilizing Avenda’s groundbreaking AI technology, Unfold AI, to launch the world’s first AI-assisted Focal One robotic high-intensity focused ultrasound (HIFU) procedures.
Tumor Ablation Market Geographical Overview
Geographically, the tumor ablation market is widespread in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is currently the largest market for tumor ablation procedures, followed by Europe and Asia Pacific.
In North America, the tumor ablation market is primarily driven by factors such as the availability of advanced healthcare infrastructure, the rising prevalence of cancer, and the increasing adoption of minimally invasive procedures. In addition, the presence of major market players and ongoing research and development activities in the region are expected to further boost the growth of the tumor ablation market in North America.
In Europe, the tumor ablation market is primarily driven by factors such as increasing healthcare expenditure, the rising prevalence of cancer, and favorable government initiatives to promote the adoption of minimally invasive procedures. In addition, the presence of a large number of leading market players in the region is expected to further drive the growth of the tumor ablation market in Europe.
In Asia Pacific, the tumor ablation market is expected to witness significant growth during the forecast period due to factors such as increasing healthcare expenditure, rising prevalence of cancer, and growing awareness about the benefits of minimally invasive procedures. In addition, the presence of a large patient pool and improving healthcare infrastructure in emerging economies such as China and India are expected to further drive the growth of the tumor ablation market in the region.
Tumor Ablation Market Competitive Landscape
The competitive landscape of the tumor ablation market is characterized by intense competition, with players competing on the basis of product offerings, pricing, distribution network, and technological advancements.
Some of the major players operating in the tumor ablation market include:
- Merit Medical Systems
- Smith & Nephew
- Galil Medical
- NeuWave Medical
The Tumor Ablation Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.
Segments Covered in the Report
- By Technology
- Radiofrequency ablation (RFA)
- Microwave ablation
- Cryoablation
- Irreversible Electroporation (IRE)
- Others
- By Mode of Treatment
- Surgical Ablation
- Percutaneous Ablation
- Laparoscopic Ablation
- By Application
- Liver Cancer
- Lung Cancer
- Prostate Cancer
- Breast Cancer
- Kidney Cancer
- Bone Cancer
- Others
- By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Region Covered in the Report
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia-Pacific (APAC)
- China
- Japan
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World (RoW)
- Brazil
- Saudi Arabia
- South Africa
- U.A.E.
- Other Countries
.png "Tumor Ablation Market Size")
Source: VynZ Research
.png "Tumor Ablation Market Analysis")
Source: VynZ Research
